CVIA Journal

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the China-German Cardiovascular Forum (CGCF) held a Joint session – New Trends on Valvular Heart Disease and Coronary Heart Disease. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Cerebral Protection in TAVR

Presenter: Professor Gerhard C. Schuler, Herzzentrum, Universitätsklinik für Kardiologie, Leipzig, Germany.

Professor Schuler discusses:

• How stroke remains a major TAVR complication, which increases mortality by threefold.
• A recent SAVR study has demonstrated a 17% stoke rate with neurologist performing NIHSS assessment.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Society for Cardiovascular Angiography and Interventions (SCAI) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

The Watchman – Indications and Clinical Update

Presenter: Kwan S. Lee, MD, FACC, FSCAI, Professor of Cardiology, University of Arizona, AZ, USA.

In this presentation Professor Lee discusses how:

• Left atrial occlusion with a Watchman device implanted with the appropriate training is safe;
• The best data is for patients who can take short term warfarin;
• There is reasonable registry data for patients who cannot take long term anticoagulation and a randomized trial is pending;
• Cost is significant and cost efficacy will ultimately decide widespread use.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the World Heart Federation (WHF) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

The Puzzle of Heart Failure with Preserved Ejection Fraction

Presenter: Professor Daniel José Piñeiro, University of Buenos Aires, Buenos Aires, Argentina.

Professor Piñeiro discusses the puzzle of HFpEF:

• Is dyspnea sufficient to diagnose HFpEF?
• Is HFpEF frequent?
• Can we die of HFpEF?
• Does HFpEF have a singular biopathology?
• Can we improve diagnosis, prognosis and treatment?

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees. 

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses. Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Korean Society of Cardio metabolic Syndrome (KSCMS) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

How to Use Statins to Maximize Cardiometabolic Benefits

Presenter: Kwang Kon Koh, MD, PhD, FACC, Gachon University of Korea, Incheon, South Korea.

Dr Kon Koh discusses statin guidelines to maximise cardiometabolic benefits:

Primary prevention

• Without risk factors for diabetes: low (for Asian) or optimal (for Caucasian) dose statins alone.
• Without risk factors for diabetes: low or optimal dose statins +/- ezetimbe combined with RAAS blockades or PPARa agonists to reduce diabetogenic effects of statins.

Secondary prevention

• In acute coronary syndrome state: potent high dose statins +/- ezetimbe/PCSK9 inhibitors/inclisiran because cardiovascular benefits of statins exceed diabetogenic or other risks.
• In stable coronary artery diseases: optimal dose statins +/- ezetimbe combined with RAAS blockades or PPARa

Further information on the 29th GW-ICC, to be held October 11th -14th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Society for Cardiovascular Angiography and Interventions (SCAI) held a Joint Forum. A video of one of these 2017 sessions, Challenges of Chronic Total Occlusion, is now available to view on the GW-ICC YouTube channel:

Chronic Total Occlusions – Retrograde Approach

Presenter: – Luis A Guzman, MD, FACC, FSCAI, Director Cardiac Catheterization Laboratory, Virginia Commonwealth University, Richmond, VA, USA.

Professor Guzman discusses the steps to successful retrograde CTO:

• Planning
• Collateral analysis
• Collateral cannulation
• Advancing the microcatheter
• Collateral wire crossing
• Collateral microcatheter crossing
• Penetrating distal CTO cap
• CTO crossing
• Externalization
• Angioplasty and stenting
• Equipment removal

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp 

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28^th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the ESC @ GW-ICC Joint Forum, which was held over four sessions, focused on the highlights of 2017 ESC Congress, to introduce the latest guidance and discuss the latest developments of ESC images, heart disease, heart failure, STEMI and valve disease.

A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Do We Really Need to Change Our Dietary Guidelines?

Presenter: Yangfeng Wu, Executive Associate Director at Peking University Clinical Research Institute, Beijing, China.

In this presentation Professor Wu discusses current Chinese dietary guidelines on cardiovascular disease.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

TAS @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) 2017 – Safety and Compliance Issues of Lipid Lowering Therapy

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Turkish Society of Cardiology (TAS) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Safety and Compliance Issues of Lipid Lowering Therapy

Presenter: Yağız Üresin, ICN, Istanbul University, Istanbul, Turkey.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

CAAC @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) 2017 – New Therapies for Acute and Chronic CHF: Cardiomems ™ and Impella® RP

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Chinese American Academy of Cardiology (CAAC) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

New Therapies for Acute and Chronic CHF: Cardiomems ™ and Impella® RP

Presenter: Richard C. Kovach, MD. FACC, FSCAI, FACP, Deborah Heart and Lung Center, NJ, USA.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the World Heart Federation (WHF) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Guidelines for The Diagnosis and Treatment of Acute and Chronic Heart Failure

Presenter: Franco Francesco Naccarella, M.D., Euro China society for Health Research and Technologies Transfer.

Professor Naccarella discusses:

• Chronic heart failure from clinical trials of combination drugs therapy.
• Evidence based treatments in clinical practice.
• International guidelines and clinical trials results updates from ESC, AHA and ACC.
• Roles of similar drugs ACE inhibitors, ANG receptors, blockers.
• Role of equivalent beta blocking agents with specific reference to long acting drugs.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the China-German Cardiovascular Forum (CGCF) held a Joint session – New Trends on Valvular Heart Disease and Coronary Heart Disease. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Interventional treatment with DEB – The German Experience

Presenter: Bernward Lauer, MD, PhD, Director of Department of Cardiology, Zentralklinik Bad Berka, Germany.

Professor Lauer discusses current uses and future directions of interventional treatment with drug eluting balloons (DEB) in Germany.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp